Stanford University, Stanford, California, USA
Judith Prochaska is an Associate Professor of Medicine with the Stanford Prevention Research Center at Stanford University.
Dr Prochaska’s research focuses on developing effective treatments for tobacco dependence with particular interest in individuals with co-occurring medical or psychiatric disorders. Over the past 7 years, Dr Prochaska has conducted six randomized controlled trials investigating tobacco treatment in >1500 smokers.
Currently, Dr Prochaska is Principal Investigator on an R01 from the National Institute of Mental Health, an evaluation of a stage-tailored computer-delivered tobacco treatment intervention initiated in the acute inpatient psychiatry setting; an R01 from the National Heart, Lung, and Blood Institute utilizing telemedicine to deliver combined smoking cessation and physical activity counseling to Alaska Native men and women residing in rural villages; a component in a NIDA-funded P50 Center grant evaluating a stage-tailored multiple risk behavior intervention with clients in addictions treatment; an R34 examining use of Twitter for building social networks to support tobacco abstinence; a pilot community-academic research award from the State of California Tobacco-Related Disease Research Program examining the effect of tobacco use on employability; and an investigator initiated research award from Pfizer examining use of varenicline with hospitalized smokers.
Dr Prochaska has authored over 120 peer-reviewed articles and is the North American Member Delegate for the Society for Research on Nicotine and Tobacco (SRNT). In 2007, she was the recipient of the SRNT Jarvik-Russell Young Investigator Award, in 2010 she received NIDA’s Division of Clinical Neuroscience & Behavioral Research Outstanding Early Career Investigator Award, and in 2011 she received the Mentor of the Year Award from the Bay Area Clinical Research Symposium.